These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33568368)

  • 1. Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study.
    Menczel Schrire Z; Phillips CL; Duffy SL; Marshall NS; Mowszowski L; La Monica HM; Gordon CJ; Chapman JL; Saini B; Lewis SJG; Naismith SL; Grunstein RR; Hoyos CM
    BMJ Open; 2021 Feb; 11(2):e041500. PubMed ID: 33568368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a Better Outcome with Melatonin compared to Placebo Administered to normalize sleep-wake cycle and treat hypoactive ICU Delirium: the Basel BOMP-AID study.
    Hollinger A; von Felten S; Sutter R; Huber J; Tran F; Reinhold S; Abdelhamid S; Todorov A; Gebhard CE; Cajochen C; Steiner LA; Siegemund M
    BMJ Open; 2020 Apr; 10(4):e034873. PubMed ID: 32354780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial.
    Cave AE; Chang DH; Münch GW; Steiner GZ
    Trials; 2019 Jun; 20(1):345. PubMed ID: 31182153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted intervention to enhance cognition in older people at risk of cognitive decline: study protocol for the Protein Omega-3 and Vitamin D Exercise Research (PONDER) study.
    Macpherson H; Brownell S; Duckham RL; Meyer B; Mirzaee S; Daly RM
    BMJ Open; 2019 May; 9(5):e024145. PubMed ID: 31072850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study).
    Lam V; Clarnette R; Francis R; Bynevelt M; Watts G; Flicker L; Orr CF; Loh P; Lautenschlager N; Reid CM; Foster JK; Dhaliwal SS; Robinson S; Corti E; Vaccarezza M; Horgan B; Takechi R; Mamo J
    BMJ Open; 2022 Feb; 12(2):e058826. PubMed ID: 35190446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.
    Adam R; Kanakarajan S; Onyeakazi U; Columb M; Galley H
    BMJ Open; 2020 Mar; 10(3):e034443. PubMed ID: 32184313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial.
    Sun Y; Feng W; Chen J; Liu M; Shi X; Wang J; Zou L; Xu T; Yang G
    BMJ Open; 2022 Jul; 12(7):e057970. PubMed ID: 35788069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin, temazepam and placebo in hospitalised older patients with sleeping problems (MATCH): a study protocol of randomised controlled trial.
    Stenveld F; Bosman S; van Munster BC; Beishuizen SJ; Hempenius L; van der Velde N; Smidt N; de Rooij SE
    BMJ Open; 2019 May; 9(5):e025514. PubMed ID: 31122969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance on the Brain: a randomised controlled trial evaluating the effect of a multimodal exercise programme on physical performance, falls, quality of life and cognition for people with mild cognitive impairment-study protocol.
    Burton E; Hill K; Ellis KA; Hill AM; Lowry M; Moorin R; McVeigh JA; Jacques A; Erickson KI; Tate J; Bernard S; Orr CF; Bongiascia L; Clarnette R; Clark ML; Williams S; Lautenschlager N
    BMJ Open; 2022 Apr; 12(4):e054725. PubMed ID: 35437246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of brain training on brain blood flow (The Cognition and Flow Study-CogFlowS): protocol for a feasibility randomised controlled trial of cognitive training in dementia.
    Beishon L; Evley R; Panerai RB; Subramaniam H; Mukaetova-Ladinska E; Robinson T; Haunton V
    BMJ Open; 2019 May; 9(5):e027817. PubMed ID: 31122994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
    PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.